SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARRIS - Another partner
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
353 2 0 AXPH
Emcee:  Paul Getman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
228 <<<<<<At Friday's last asked quote, the arbitrage was moschirodoc-11/10/1997
227 <<<<<.a 35 cent benefit. don't you think market makers and chirodoc-11/9/1997
226 I may have started something here by accident, but I am also interested in hearCYBERKEN-11/9/1997
225 Chirodoc::I bought a little of both. The difference seems to have narrowed a liCYBERKEN-11/9/1997
224 Chirodoc, I also added to Arris this week, but I did so by buying Sequana. It&John Metcalf-11/9/1997
223 <<<<<<As far as John Walker and David Robinson of Ligand are chirodoc-11/9/1997
222 Cyberken-Henri Termeer is the CEO of GENZ. As far as John Walker and David RoJames Silverman-11/9/1997
221 <<<<<I've been out of both stocks recently, but took the oppchirodoc-11/9/1997
220 Cy, I basically agree with your take on the merger, although I wouldn't be Andrew H-11/9/1997
219 The attraction of the new company will definitely be the vertically and horizonCYBERKEN-11/8/1997
218 When I spoke to IR at ARRS last month I was under the impression that they woulLarry Liebman-11/8/1997
217 It's all just IMO: I don't think ARRS will run away from anybody in theCYBERKEN-11/8/1997
216 Henri Tremeer is chairman of Genzyme. Jim McCamant referred to him as "oneCYBERKEN-11/8/1997
215 Cyberken, Can you tell me what co's. does Tremeirs and Robinson run Thanks j.d.robbins-11/8/1997
214 CYBERKEN; Since it is apparent you know much more about ARRS than I would you mSteve Lokness-11/8/1997
213 While the initial benefit of the merger was to Sequanna's stock, I think ArCYBERKEN-11/8/1997
212 <<<<<<What about one of these companies doing a SQNA/ARRS? .chirodoc-11/4/1997
211 Good point, Larry. There are some tipoffs in business plans. For example, AgoJohn Metcalf-11/4/1997
210 David Stone of Cowen is quoted as predicting that "...such mergers will beLarry Liebman-11/4/1997
209 <<<<My kids are in the same time range .......may our kids both bechirodoc-11/4/1997
208 My kids are in the same time range. IMO biotech will solve a lot of those finanCYBERKEN-11/4/1997
207 <<<<<< If your in for that reasonable 3-5 years, you gotta bechirodoc-11/4/1997
206 With just a cursory look at the fundamentals, it seems that the new co will be CYBERKEN-11/4/1997
205 <<<<<<I think its just the beginning of the market's affachirodoc-11/4/1997
204 I think its just the beginning of the market's affair with biotechs. ThankAndrew H-11/3/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News